14.20

2.81% -0.41

After Hours: 14.91 0.71 +5.00%

SI-BONE Inc (SIBN)

Overview News Price History Option Chain Financials Discussions Forecast

SI-BONE Inc stock is currently priced at $14.20, with a 24-hour trading volume of 394.62K. It has seen a -2.81% decreased in the last 24 hours and a -10.41% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $14.60 pivot point. If it approaches the $14.18 support level, significant changes may occur.

Previous Close:

$14.61

Open:

$14.79

24h Volume:

394.62K

Market Cap:

$585.10M

Revenue:

$138.89M

Net Income/Loss:

$-43.34M

P/E Ratio:

-10.52

EPS:

-1.35

Net Cash Flow:

$-26.51M

1W Performance:

-2.54%

1M Performance:

-10.41%

6M Performance:

-20.98%

1Y Performance:

-41.49%

1D Range:

$14.07

$15.04

52W Range:

$14.07

$29.51

SI-BONE Inc Stock (SIBN) Company Profile

Name

SI-BONE Inc

Sector

Healthcare (1213)

Industry

Medical Devices (160)

Phone

408-207-0700

Address

471 El Camino Real, Suite 101, Santa Clara, CA

Employee

Twitter

@siboneinc

Next Earnings Date

2024-05-14

Latest SEC Filings

SIBN's Discussions on Twitter

SI-BONE Inc Stock (SIBN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-12-22	Initiated	Jefferies	Buy
Apr-07-22	Resumed	Cantor Fitzgerald	Overweight
Jun-08-21	Initiated	Citigroup	Buy
Mar-09-21	Reiterated	Needham	Buy
Dec-16-20	Reiterated	Needham	Buy
Aug-04-20	Reiterated	Needham	Buy
Jun-16-20	Resumed	Cantor Fitzgerald	Overweight
May-05-20	Reiterated	Needham	Buy
Feb-19-20	Initiated	Needham	Buy
Jan-08-20	Initiated	SunTrust	Buy
Dec-18-19	Initiated	Cantor Fitzgerald	Overweight
Nov-12-18	Initiated	BofA/Merrill	Buy
Nov-12-18	Initiated	Canaccord Genuity	Buy
Nov-12-18	Initiated	JMP Securities	Mkt Outperform
Nov-12-18	Initiated	Morgan Stanley	Overweight

View All

SI-BONE Inc Stock (SIBN) Latest News

Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks Investment Research

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

GlobeNewswire Inc.

Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings

Zacks Investment Research

SI-BONE Inc Stock (SIBN) Financials Data

SI-BONE Inc (SIBN) Revenue 2024

SIBN reported a revenue (TTM) of $138.89 million for the quarter ending December 31, 2023, a +30.52% rise year-over-year.

SI-BONE Inc (SIBN) Net Income 2024

SIBN net income (TTM) was -$43.34 million for the quarter ending December 31, 2023, a +29.25% increase year-over-year.

SI-BONE Inc (SIBN) Cash Flow 2024

SIBN recorded a free cash flow (TTM) of -$26.51 million for the quarter ending December 31, 2023, a +48.18% increase year-over-year.

SI-BONE Inc (SIBN) Earnings per Share 2024

SIBN earnings per share (TTM) was -$1.14 for the quarter ending December 31, 2023, a +36.31% growth year-over-year.

SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.